Clinical trial Recruiting at 1 site Observational Ages 18 and up

Measuring eye changes to detect dementia

Official title: Dynamic Light Scattering Ocular Measurement in the Detection of Dementia

Run by MD Stem Cells · NCT06613971 · Data updated 2026-11-12

This study is testing a new eye exam to see if it can help tell the difference between people with and without dementia.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorMD Stem Cells
Industry-sponsored
Locations1 site (Coconut Creek, Florida)
StatusRecruiting
StartedApril 25, 2024
Main results expectedApril 25, 2027
Study endsApril 25, 2028
Registry record updatedMay 8, 2025
Trial IDNCT06613971 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals capable of undergoing an ophthalmic evaluation and providing informed consent.

Probably not a fit

Patients who are not medically stable or at significant health risk may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the utility of dynamic light scattering spectroscopy, a noninvasive technique, in differentiating between patients with and without dementia by measuring changes in the eye. The research focuses on identifying which types of dementia can be detected and at what stages using this method. Participants will undergo an ophthalmic evaluation to ensure they can cooperate with the testing process. The study seeks to provide a new diagnostic tool for dementia, which is currently challenging to diagnose definitively until posthumously.

Why it matters

Potential benefit: If successful, this study could lead to earlier and more accurate diagnoses of dementia, improving patient management and care.

How similar studies have gone: While the approach of using eye measurements for dementia detection is innovative, similar studies have shown promise in exploring noninvasive diagnostic techniques for neurological conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
1. All patients must be capable of an adequate ophthalmic evaluation and testing. This includes the ability to cooperate with the exam, sufficiently clear media (cornea, lens, vitreous) and sufficient pupillary dilation.
2. Patients must be capable of providing informed consent.
3. Patients who are not medically stable or who may be at significant risk to their health will not be eligible.
4. Women of child bearing age must not be pregnant at the time of examination.

Where it's running

  • 3T Radiology
    Coconut Creek, Florida, United States
    Recruiting

Study contacts

  • Principal investigator: Jeffrey N Weiss, MD — The Healing Institute
  • Study coordinator: Jeffrey N Weiss, MD
  • Email: jweissmd@me.com
  • Phone: 954-608-7604

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.